Compound Detail
CHEMBL5286474
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL5286474 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | VBSXZLUOPFVFLH-UHFFFAOYSA-N |
3
Targets
3
Activities
1
Assay Types
0
PK Parameters
5
Publications
0
Known Names
Molecular Properties
451.4
MW (Da)
3.69
ALogP
5
HBA
3
HBD
104.3
PSA (Ų)
0.41
QED
0
Ro5 Violations
6
Rot. Bonds
Drug Information
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 3 meas. best 7.82
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| HT-29 CHEMBL384 | IC50 | 7.82 | 7.82 | 15.1 | 1 |
| HepG2 CHEMBL395 | IC50 | 7.75 | 7.75 | 17.9 | 1 |
| Bromodomain-containing protein 4 CHEMBL1163125 | IC50 | 6.21 | 6.21 | 620.6 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| HT-29 | IC50 | = | 15.12 | nM | 7.82 | Antiproliferative activity against human HT-29 cells assessed as reduction in ce... | 36599264 |
| HepG2 | IC50 | = | 17.86 | nM | 7.75 | Antiproliferative activity against human HepG2 cells assessed as reduction in ce... | 36599264 |
| Bromodomain-containing protein 4 | IC50 | = | 620.6 | nM | 6.21 | Inhibition of BRD4 BD1 (unknown origin) by TR-FRET assay | 36599264 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 36599264 | 10.1016/j.bmc.2022.117152 | Bromodomain-containing protein 4 | 2 |
| 36599264 | 10.1016/j.bmc.2022.117152 | MCF7 | 1 |
| 36599264 | 10.1016/j.bmc.2022.117152 | HepG2 | 1 |
| 36599264 | 10.1016/j.bmc.2022.117152 | HT-29 | 1 |
| 36599264 | 10.1016/j.bmc.2022.117152 | GES1 | 1 |
Data from ChEMBL 36 via Core Engine